Chunhui Wu Selected Research

Caveolin 1

1/2019	Shear stress promotes anoikis resistance of cancer cells via caveolin-1-dependent extrinsic and intrinsic apoptotic pathways.
1/2018	Correction: Mechanosensitive caveolin-1 activation-induced PI3K/Akt/mTOR signaling pathway promotes breast cancer motility, invadopodia formation and metastasis in vivo.
10/2017	[Caveolin-1 in relation with mitochondria and cancer metabolism-a promising target for cancer therapy].
1/2017	Involvement of caveolin-1 in low shear stress-induced breast cancer cell motility and adhesion: Roles of FAK/Src and ROCK/p-MLC pathways.
3/2016	Mechanosensitive caveolin-1 activation-induced PI3K/Akt/mTOR signaling pathway promotes breast cancer motility, invadopodia formation and metastasis in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chunhui Wu Research Topics

Disease

70	Neoplasms (Cancer) 10/2022 - 07/2006
22	Breast Neoplasms (Breast Cancer) 01/2022 - 03/2014
11	Leukemia 11/2010 - 09/2006
10	Neoplasm Metastasis (Metastasis) 01/2021 - 03/2014
6	Catalepsy 01/2021 - 01/2016
3	Inflammation (Inflammations) 01/2022 - 01/2013
3	Weight Gain 01/2018 - 01/2016
2	Hypoxia (Hypoxemia) 01/2022 - 07/2015
2	Iron Deficiencies 01/2022 - 01/2019
2	Schizophrenia (Dementia Praecox) 01/2021 - 10/2020
2	Orthostatic Hypotension (Postural Hypotension) 01/2018 - 01/2017
2	Hepatocellular Carcinoma (Hepatoma) 01/2010 - 08/2009
1	Anemia 01/2022
1	Pulmonary Hypertension 01/2022
1	Dehydration (Water Stress) 01/2022
1	Hyperthermia 10/2021
1	Myocardial Infarction 05/2021

Drug/Important Bio-Agent (IBA)

25	Pharmaceutical PreparationsIBA 01/2021 - 07/2006
8	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2019 - 02/2007
7	Daunorubicin (Cerubidine)FDA LinkGeneric 06/2010 - 09/2006
6	Small Interfering RNA (siRNA)IBA 08/2018 - 11/2014
5	1-phenyl-3,3-dimethyltriazene (PDT)IBA 03/2022 - 01/2016
5	Proteins (Proteins, Gene)FDA Link 10/2020 - 12/2015
5	Caveolin 1IBA 01/2019 - 03/2016
4	MicellesIBA 10/2022 - 03/2015
4	CytokinesIBA 01/2022 - 01/2018
4	IntegrinsIBA 01/2020 - 03/2014
4	Phencyclidine (Angel Dust)IBA 04/2019 - 01/2016
4	Antineoplastic Agents (Antineoplastics)IBA 04/2011 - 02/2007
3	Therapeutic UsesIBA 03/2022 - 01/2018
3	Photosensitizing Agents (Photosensitizers)IBA 01/2022 - 01/2017
3	Contrast MediaIBA 01/2021 - 01/2015
3	GraphiteIBA 01/2020 - 01/2017
3	Polylactic Acid-Polyglycolic Acid CopolymerIBA 01/2020 - 04/2014
3	Silicon Dioxide (Silica)FDA LinkGeneric 01/2019 - 01/2011
3	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 08/2018 - 08/2009
3	NickelIBA 08/2009 - 05/2008
2	Glutathione (Reduced Glutathione)IBA 03/2022 - 01/2021
2	Biological ProductsIBA 01/2022 - 01/2021
2	ElementsIBA 01/2022 - 10/2009
2	polyacrylamideIBA 01/2022 - 01/2019
2	Protein Isoforms (Isoforms)IBA 01/2022 - 01/2019
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 10/2020
2	Singlet OxygenIBA 11/2021 - 05/2017
2	Adenosine Triphosphate (ATP)IBA 11/2021 - 08/2018
2	Serotonin (5 Hydroxytryptamine)IBA 01/2021 - 01/2018
2	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 10/2020
2	MicroRNAs (MicroRNA)IBA 10/2020 - 01/2018
2	AcidsIBA 01/2020 - 06/2010
2	Cyclin D1IBA 11/2019 - 01/2018
2	Interleukin-6 (Interleukin 6)IBA 02/2018 - 01/2018
2	LipopolysaccharidesIBA 01/2018 - 01/2013
2	VimentinIBA 07/2017 - 07/2015
2	Fibronectins (Fibronectin)IBA 07/2017 - 07/2015
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017 - 01/2015
2	GoldIBA 01/2017 - 08/2009
2	Histamine H1 Receptors (Histamine H1 Receptor)IBA 01/2017 - 01/2016
2	LigandsIBA 04/2016 - 04/2011
2	CyclodextrinsIBA 03/2016 - 11/2010
2	Folic Acid (Vitamin M)FDA LinkGeneric 11/2014 - 01/2011
2	Fluorescein-5-isothiocyanate (FITC)IBA 01/2013 - 01/2011
2	Carboxylic AcidsIBA 08/2012 - 04/2011
2	titanium dioxide (Titania)FDA Link 09/2009 - 12/2007
1	Indoleamine-Pyrrole 2,3,-Dioxygenase (Indoleamine 2,3 Dioxygenase)IBA 10/2022
1	4- (2- (2- hydroxycyclohexylamino)benzothiazol- 6- yloxy)pyridine- 2- carboxylic acid methylamideIBA 10/2022
1	AntigensIBA 10/2022
1	Macrophage Colony-Stimulating FactorIBA 10/2022
1	NanovaccinesIBA 10/2022
1	OvalbuminIBA 10/2022
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 10/2022
1	Reactive Nitrogen SpeciesIBA 03/2022
1	Sildenafil Citrate (Viagra)FDA Link 01/2022
1	AntioxidantsIBA 01/2022
1	IronIBA 01/2022
1	MonocrotalineIBA 01/2022
1	Hormones (Hormone)IBA 01/2022
1	Myosin Type IIIBA 01/2022
1	GelsIBA 01/2022
1	Methylene Blue (Methylthioninium Chloride)FDA Link 01/2022
1	Interleukin-12 (IL 12)IBA 01/2022
1	ChlorophyllIBA 01/2022
1	Hyaluronic Acid (Hyaluronan)IBA 11/2021
1	1- cyclohexyl- 2- (5H- imidazo(5,1- a)isoindol- 5- yl)ethanolIBA 11/2021
1	APTIBA 10/2021
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 05/2021
1	reteplase FDA Link 05/2021
1	Tissue Plasminogen Activator (Alteplase)FDA Link 05/2021

Therapy/Procedure

33	Therapeutics 03/2022 - 03/2007
12	Precision Medicine 01/2021 - 01/2015
10	Drug Therapy (Chemotherapy) 10/2021 - 09/2006
8	Lasers (Laser) 11/2021 - 12/2007
6	Immunotherapy 10/2022 - 02/2018
5	Photothermal Therapy 01/2020 - 01/2017
4	Photochemotherapy (Photodynamic Therapy) 01/2020 - 02/2012
3	Phototherapy (Light Therapy) 01/2021 - 01/2016
3	Quantum Dots (Quantum Dot) 01/2019 - 01/2010
2	Radiotherapy 06/2015 - 03/2015
2	Aftercare (After-Treatment) 03/2015 - 11/2009
1	Biological Therapy 01/2022
1	Oral Administration 01/2022